Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Exelixis, Inc. (EXEL) Institutional Ownership & Insider Trading

756 institutions reported holding Exelixis, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 33 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-07-03 · read by EquiReason

EXELExelixis, Inc.Follow EXEL — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
16.0B
P/E TTM
20.3
Dividend yield
—
52-week
—
Next earnings
29 Oct, in 5 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

756 institutions held —% of the shares. Across filers that reported both quarters, shares held changed -1.0%.

Increased+228New+102Decreased-262Closed-50

Largest moves, shares (millions)

Two Sigma Investments+2.0MD. E. Shaw+1.9MUBS Group AG+0.8MAQR Capital Management-2.1MLos Angeles Capital…-1.9MBlackRock-1.7M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+3.9Sep 24-2.4Dec 24+3.3Mar 25+1.1Jun 25-2.1Sep 25+13.3Dec 25-6.2Mar 26-2.5Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 26756260-1.0%22810226250
Mar 26691257-2.6%2237523659
Dec 25664268+5.3%2057521148
Sep 25605251-0.9%1966021872
Jun 25623254+0.4%21110519831
Mar 25547250+1.3%1987615644
Dec 24510250-1.0%1598114632
Sep 24444245+1.9%1276914833

Exelixis, Inc. — questions

Who owns Exelixis, Inc. stock?
756 institutions reported Exelixis, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (11.7%), FARALLON CAPITAL MANAGEMENT LLC (5.4%), RENAISSANCE TECHNOLOGIES LLC (5.4%).
Are Exelixis, Inc. insiders buying or selling?
33 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Exelixis, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.